Ambrisentan
Ambrisentan_label (Ambrisentan Label)
Ambrisentan Powder
FDA Label NDC 50137-4051
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Veranova, L.p. for the product Ambrisentan (NDC 50137-4051). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding ambrisentan, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
